Solutions for health equity, treatments for heart failure, and the use of technology in prevention and patient care are just some of the topics on the agenda for the 2021 American Heart Association (AHA) Scientific Sessions, which will take place Saturday through Monday in a virtual format.
Solutions for health equity, treatments for heart failure, and the use of technology in prevention and patient care are just some of the topics on the agenda for the 2021 American Heart Association (AHA) Scientific Sessions, which will take place Saturday through Monday in a virtual format.
AHA had hoped to gather in Boston for the first major in-person cardiovascular meeting since the start of the pandemic, but organizers decided in September to switch to a virtual format for the second year.
Of course, the effects of COVID-19—and what care for cardiovascular disease (CVD) will look like after the pandemic—will be part of the meeting. Saturday’s highlight will be a talk on vaccine development and CVD with Mikael Doelstein, MD, PhD, Pfizer’s chief scientific offer and president, and Stéphane Bancel, CEO of Moderna. The opening session features a look at care post-COVID-19 with AHA President Donald M. Lloyd-Jones, MD, ScM, FAHA, and Manesh R. Patel, MD, FAHA, chair of the scientific program.
Health equity is a theme for Sunday, led by the session “Achieving Health Equity: Advancing to Solutions.” The session will be moderated by heart failure specialist Clyde W. Yancy, MD, MSc, FAHA, of Northwestern University, who is also the 2021 recipient of the AHA Chairman’s award. Yancy, one of the most highly cited heart failure investigators in the world, serves as both vice dean of diversity and inclusion and chief of cardiology in the Department of Medicine at the Feinberg School of Medicine.
And, of course, there are clinical trials galore, starting with Saturday morning’s presentations in cardiothoracic surgery. Studies on hypertension, technology, and the impacts of the pandemic will be presented Saturday afternoon. A study from Brigham and Women’s Hospital in Boston will examine the effects of a remotely delivered hypertension and lipid program across a health system.
Results coming Sunday include those from CRAVE, or Cardiovascular Risk Factors Affecting Vascular Age; and EMPULSE, which will examine the effects of empagliflozin in patients hospitalized for heart failure. A late-breaking session devoted to “information overload” in digital health will feature REVeAL-HF, on using data to evaluate risk in clinical decision-making in heart failure, and the Fitbit Heart study, which examined the ability of the consumer wearable to detect atrial fibrillation.
Monday will revisit the discussion on the value of purified fish oil treatment, with PREPARE-IT 2, examining the effects of icosapent ethyl vs placebo in outpatients with COVID-19.
Therapies new and old will be covered in Monday’s trial presentations, including ASCEND, which examines the effects of aspirin on dementia, and REVERSE-IT, which looks at bentracimab on hemostasis in patients taking ticagrelor in acute situations. Another study will present results for an oral PCSK9 inhibitor to reduce low-density lipoprotein cholesterol.
Virtual attendees will also have the chance to hear as the lead author of EMPEROR-Preserved, Stefan D. Anker, MD, drills down into the data from that groundbreaking trial presented at the European Society of Cardiology earlier this year. A Monday morning session, “From Failure to Success: Advances in Heart Failure,” will offer updates on a host of newer therapies, including vericiguat, finerenone, and drugs in the sodium-glucose co-transporter 2 (SGLT2) inhibitor class.
The American Journal of Managed Care® will have coverage of the AHA Scientific Sessions starting Saturday. For full coverage, visit our AHA conference page at https://www.ajmc.com/conference/aha.
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
A Focus on Women: AUA Best Posters Highlight Female Athletes, Prenatal Care, and Women in Urology
May 9th 2024Three posters from the American Urological Association (AUA) 2024 Annual Meeting focused on urinary incontinence in female athletes, prenatal care for fetuses with spina bifida in California, and the experiences of women residents at the Brady Urological Institute.
Read More